Profile data is unavailable for this security.
About the company
Zota Health Care Limited is an India-based pharmaceutical company, which is engaged in manufacturing and marketing of pharmaceutical products catering to domestic and international markets. It engages in manufacturing, marketing, and exporting a range of pharmaceutical, ayurvedic, nutraceutical, and over the counter (OTC) products. The Company’s business model comprises three verticals, namely Domestic, Exports and Retail Pharmacy Chain. Its Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products. Its products span across approximately 24 divisions, with a portfolio of over 4,000 therapeutic product categories such as generics, OTC products, allopathic, ayurvedic, and others. Its Retail Pharmacy Chain business vertical operates a chain of approximately 594 pharmacy stores under the brand Davaindia. Its Domestic products include AZIVAR-100 DT Tab, AZIVAR-250 Tab, AZIVAR-500 Tab, AZIVAR-CX Tab, among others.
- Revenue in INR (TTM)1.98bn
- Net income in INR-242.34m
- Incorporated2000
- Employees445.00
- LocationZota Health Care LtdZota House 2/896Hira Modi Street SagrampuraSURAT 395002IndiaIND
- Phone+91 2 612331601
- Websitehttps://www.zotahealthcare.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jagsonpal Pharmaceuticals Ltd | 2.10bn | 203.13m | 10.85bn | 1.03k | 54.21 | -- | 47.90 | 5.17 | 7.57 | 7.57 | 78.03 | -- | -- | -- | -- | 2,048,663.00 | -- | 10.95 | -- | 13.29 | 56.41 | 58.13 | 9.67 | 9.21 | -- | 26.27 | -- | 43.81 | -11.83 | 4.58 | -15.94 | 25.50 | -35.69 | 82.06 |
| Bajaj Healthcare Ltd | 4.76bn | -133.27m | 11.95bn | 944.00 | -- | -- | 81.22 | 2.51 | -4.82 | -10.30 | 172.62 | -- | -- | -- | -- | 5,041,608.00 | -- | 7.67 | -- | 14.11 | 48.43 | 33.26 | -2.80 | 7.99 | -- | 1.74 | -- | 4.90 | -26.69 | 5.04 | -122.55 | -- | 15.08 | -- |
| Ngl Fine Chem Ltd | 3.58bn | 420.29m | 13.12bn | 390.00 | 31.22 | -- | 34.02 | 3.66 | 68.03 | 68.03 | 580.00 | -- | -- | -- | -- | 9,188,328.00 | -- | 15.06 | -- | 19.58 | 52.02 | 43.53 | 11.73 | 13.15 | -- | 26.59 | -- | 3.06 | 21.79 | 17.20 | 101.58 | 15.47 | 14.49 | 0.00 |
| Bliss GVS Pharma Ltd | 7.94bn | 814.66m | 13.64bn | 831.00 | 17.02 | -- | 11.73 | 1.72 | 7.63 | 7.63 | 74.93 | -- | -- | -- | -- | 9,559,162.00 | -- | 6.46 | -- | 8.22 | 51.81 | 43.91 | 11.24 | 9.92 | -- | -- | -- | 7.92 | 2.48 | -3.03 | 6.49 | -9.42 | -8.33 | -12.94 |
| Lincoln Pharmaceuticals Ltd | 5.92bn | 979.63m | 14.60bn | 1.70k | 14.90 | -- | 13.36 | 2.47 | 48.91 | 48.91 | 295.69 | -- | -- | -- | -- | 3,483,600.00 | -- | 13.95 | -- | 16.54 | 51.92 | 50.65 | 16.54 | 14.71 | -- | 60.93 | -- | 3.44 | 13.76 | 9.66 | 27.99 | 13.88 | 21.54 | 3.71 |
| Remus Pharmaceuticals Ltd | 450.27m | 85.03m | 14.67bn | 38.00 | 155.81 | 56.47 | 163.36 | 32.58 | 15.98 | 15.98 | 90.25 | 44.09 | -- | -- | -- | 11,849,290.00 | -- | -- | -- | -- | 52.39 | -- | 18.88 | -- | 1.35 | -- | 0.2933 | -- | 82.17 | -- | 151.14 | -- | -- | -- |
| Kopran Ltd | 6.37bn | 592.79m | 15.59bn | 358.00 | 22.26 | -- | 21.42 | 2.45 | 14.53 | 14.53 | 150.01 | -- | -- | -- | -- | 17,794,040.00 | -- | 8.47 | -- | 12.23 | 36.03 | 32.93 | 9.31 | 8.89 | -- | 27.17 | -- | 25.41 | 11.54 | 11.42 | 87.11 | 16.23 | 12.53 | -- |
| JG Chemicals Ltd | -100.00bn | -100.00bn | 16.18bn | 56.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -14.90 | -- | -43.84 | -- | -- | -- |
| Beta Drugs Ltd | 2.96bn | 364.37m | 16.34bn | 315.00 | 44.83 | 10.40 | 35.34 | 5.52 | 37.90 | 37.90 | 307.60 | 163.43 | 1.31 | 4.51 | 4.17 | -- | 16.10 | 15.10 | 23.91 | 22.23 | 38.73 | 39.77 | 12.32 | 12.38 | 1.51 | 17.81 | 0.0654 | -- | 30.21 | 35.01 | 18.62 | 35.29 | -10.89 | -- |
| Zota Health Care Ltd | 1.98bn | -242.34m | 17.52bn | 445.00 | -- | -- | 3,752.02 | 8.84 | -9.27 | -9.27 | 76.32 | -- | -- | -- | -- | 4,452,605.00 | -- | -1.38 | -- | -1.85 | 49.86 | 35.95 | -12.23 | -1.33 | -- | -2.87 | -- | -- | 28.96 | 16.08 | -148.54 | -- | 39.85 | 0.00 |
| Windlas Biotech Ltd | 6.61bn | 596.01m | 18.38bn | 1.15k | 30.83 | -- | 24.16 | 2.78 | 28.52 | 28.52 | 316.58 | -- | -- | -- | -- | 5,730,702.00 | -- | -- | -- | -- | 37.39 | -- | 9.01 | -- | -- | 48.16 | -- | -- | 22.97 | -- | 36.51 | -- | -- | -- |
| Panacea Biotec Ltd | 5.46bn | -279.53m | 19.24bn | 1.15k | -- | -- | 253.27 | 3.53 | -4.58 | -4.58 | 89.84 | -- | -- | -- | -- | 4,761,763.00 | -- | 10.26 | -- | 16.53 | 60.24 | 50.27 | -5.20 | 24.87 | -- | -17.30 | -- | 0.00 | 21.57 | 4.13 | 96.47 | -- | 74.65 | -- |
| Sigachi Industries Ltd | 4.10bn | 594.65m | 19.48bn | 991.00 | 36.44 | -- | 27.39 | 4.75 | 1.60 | 1.60 | 10.97 | -- | -- | -- | -- | 4,136,886.00 | -- | 14.77 | -- | 19.57 | 52.33 | 50.30 | 14.43 | 14.92 | -- | 7.19 | -- | 1.61 | 32.08 | 25.34 | 31.34 | 24.64 | 70.35 | -- |
| Hester Biosciences Ltd | 2.99bn | 193.56m | 20.69bn | 642.00 | 104.55 | -- | 54.66 | 6.92 | 23.26 | 23.26 | 350.03 | -- | -- | -- | -- | 4,656,698.00 | -- | 6.15 | -- | 7.69 | 71.52 | 66.64 | 7.34 | 12.83 | -- | 2.26 | -- | 23.27 | 14.45 | 11.33 | -29.06 | -14.59 | 1.49 | -11.42 |
| Syncom Formulations (India) Ltd | 2.91bn | 285.50m | 21.35bn | 802.00 | 69.67 | -- | 63.78 | 7.34 | 0.326 | 0.326 | 2.99 | -- | -- | -- | -- | 3,626,019.00 | -- | 7.50 | -- | 10.23 | 39.53 | 34.10 | 9.82 | 9.38 | -- | 7.67 | -- | -- | 17.45 | 7.12 | 26.13 | 17.95 | -- | -- |
| Amrutanjan Health Care Ltd | 4.27bn | 425.73m | 23.16bn | 635.00 | 54.50 | -- | 47.43 | 5.42 | 14.71 | 14.71 | 147.56 | -- | -- | -- | -- | 6,726,040.00 | -- | 16.22 | -- | 20.12 | 49.61 | 53.09 | 9.97 | 13.23 | -- | 212.51 | -- | 18.95 | 10.96 | 10.71 | 12.90 | 12.46 | 26.93 | 16.43 |
